Finance

Beta
Lists
8Z1:FRA
PharmaEssentia Reg S GDR
€15.50
0.00%
(0.00) 1D
Mar 9, 9:34:57 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8Z1...
Mkt. cap
416.01B
Volume
0.00
52-wk high
€15.50
52-wk low
€15.50
No. of employees
131
Mkt. cap
416.01B
Volume
0.00
52-wk high
€15.50
52-wk low
€15.50
No. of employees
131
News stories
From sources across the web
About PharmaEssentia Reg S GDR
CEO-
Employees131
FoundedMay 9, 1990
Headquarters-
SectorBiotechnology
Websitepharmaessentia.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.60B
3.89B
4.88B
5.12B
Cost of goods sold
450.20M
327.93M
543.68M
621.28M
Cost of revenue
450.20M
327.93M
543.68M
621.28M
Research and development expenses
828.53M
884.63M
1.01B
857.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.23B
1.52B
1.77B
1.56B
Operating expense
2.06B
2.40B
2.78B
2.41B
Total operating expenses
2.51B
2.73B
3.32B
3.03B
Operating income
1.10B
1.17B
1.56B
2.09B
Other non operating income
4.48M
238.00K
4.37M
1.32M
EBT including unusual items
95.82M
1.41B
2.01B
2.34B
EBT excluding unusual items
95.82M
1.41B
2.01B
2.34B
Income tax expense
-736.43M
-59.18M
536.45M
185.95M
Effective tax rate
-768.54%
-4.19%
26.65%
7.96%
Other operating expenses
-
-
-
-
Net income
832.25M
1.47B
1.48B
2.15B
Net profit margin
23.10%
37.83%
30.24%
41.97%
Earnings per share
2.24
3.99
3.97
5.78
Interest and investment income
175.57M
123.73M
142.46M
139.53M
Interest expense
-8.83M
-5.55M
-5.76M
-4.71M
Net interest expenses
166.75M
118.18M
136.70M
134.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.13B
1.20B
1.60B
2.14B
Gain or loss from assets sale
-
-
1.50M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer